Kang YS - Search Results

1

Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats.

Cha DR, Kang YS, Han SY, Jee YH, Han KH, Han JY, Kim YS, Kim NH. Cha DR, et al. Among authors: kang ys. J Endocrinol. 2004 Oct;183(1):183-94. doi: 10.1677/joe.1.05647. J Endocrinol. 2004. PMID: 15525586

2

Effect of retinoic acid in experimental diabetic nephropathy.

Han SY, So GA, Jee YH, Han KH, Kang YS, Kim HK, Kang SW, Han DS, Han JY, Cha DR. Han SY, et al. Among authors: kang ys, kang sw. Immunol Cell Biol. 2004 Dec;82(6):568-76. doi: 10.1111/j.1440-1711.2004.01287.x. Immunol Cell Biol. 2004. PMID: 15550114

3

Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy.

Kim NH, Oh JH, Seo JA, Lee KW, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR. Kim NH, et al. Among authors: kang ys. Kidney Int. 2005 Jan;67(1):167-77. doi: 10.1111/j.1523-1755.2005.00067.x. Kidney Int. 2005. PMID: 15610240 Free article.

4

Effect of IgA aggregates on transforming growth factor-beta1 production in human mesangial cells and the intraglomerular expression of transforming growth factor-beta1 in patients with IgA nephropathy.

Han SY, Ihm CG, Cha DR, Kang YS, Han KH, Kim HK, Han JY. Han SY, et al. Among authors: kang ys. Korean J Intern Med. 2005 Mar;20(1):40-7. doi: 10.3904/kjim.2005.20.1.40. Korean J Intern Med. 2005. PMID: 15906952 Free PMC article.

5

Role of aldosterone in diabetic nephropathy.

Cha DR, Kang YS, Han SY, Jee YH, Han KH, Kim HK, Han JY, Kim YS. Cha DR, et al. Among authors: kang ys. Nephrology (Carlton). 2005 Oct;10 Suppl:S37-9. doi: 10.1111/j.1440-1797.2005.00455.x. Nephrology (Carlton). 2005. PMID: 16174286

6

High glucose and angiotensin II increase beta1 integrin and integrin-linked kinase synthesis in cultured mouse podocytes.

Han SY, Kang YS, Jee YH, Han KH, Cha DR, Kang SW, Han DS. Han SY, et al. Among authors: kang ys, kang sw. Cell Tissue Res. 2006 Feb;323(2):321-32. doi: 10.1007/s00441-005-0065-4. Epub 2005 Sep 28. Cell Tissue Res. 2006. PMID: 16189717

7

Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.

Han SY, Kim CH, Kim HS, Jee YH, Song HK, Lee MH, Han KH, Kim HK, Kang YS, Han JY, Kim YS, Cha DR. Han SY, et al. Among authors: kang ys. J Am Soc Nephrol. 2006 May;17(5):1362-72. doi: 10.1681/ASN.2005111196. Epub 2006 Mar 29. J Am Soc Nephrol. 2006. PMID: 16571782

8

Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes.

Kang YS, Park YG, Kim BK, Han SY, Jee YH, Han KH, Lee MH, Song HK, Cha DR, Kang SW, Han DS. Kang YS, et al. Among authors: kang sw. J Mol Endocrinol. 2006 Apr;36(2):377-88. doi: 10.1677/jme.1.02033. J Mol Endocrinol. 2006. PMID: 16595708 Free article.

9

An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.

Han SY, Jee YH, Han KH, Kang YS, Kim HK, Han JY, Kim YS, Cha DR. Han SY, et al. Among authors: kang ys. Nephrol Dial Transplant. 2006 Sep;21(9):2406-16. doi: 10.1093/ndt/gfl238. Epub 2006 May 25. Nephrol Dial Transplant. 2006. PMID: 16728425

10

Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.

Ko GJ, Kang YS, Han SY, Lee MH, Song HK, Han KH, Kim HK, Han JY, Cha DR. Ko GJ, et al. Among authors: kang ys. Nephrol Dial Transplant. 2008 Sep;23(9):2750-60. doi: 10.1093/ndt/gfn157. Epub 2008 Apr 3. Nephrol Dial Transplant. 2008. PMID: 18388116

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

771 results

Search Page

Filters